A photo of Richard Graham.

Member, Division of Oncology

Assistant Professor, UC Department of Pediatrics

513-636-0842

"When I treat a person with a brain tumor, I want to help them and their family make the most of their lives."

Biography & Affiliation

Biography

As a neuro-oncologist, I specialize in treating brain tumors. When I treat a person with a brain tumor, I want to help them and their family make the most of their lives.

Brain tumors represent a convergence of some of the most important questions in science and some of the most challenging situations in life. New research on the molecular mechanisms underlying the development of tumors is opening up opportunities to target those tumors in ways that haven't been explored yet. At the same time, families impacted by brain tumors find themselves in a situation that can be overwhelmingly unfamiliar and difficult. This exciting research and a desire to help these families is why I chose to be a neuro-oncologist.

In my research, we are trying to use new tools to understand the molecular machinery that makes tumors work so we can target those mechanisms specifically with as little risk as possible to the patient.

My own children remind me that life is too important not to have fun and spend time with the people you love. We don't have any trouble filling our "spare" time!

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Research Divisions

Oncology

Publications

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. Graham, RT; Abu-Arja, MH; Stanek, JR; Cappellano, A; Coleman, C; Chi, S; Cooney, T; Dhall, G; Ellen, JG; Finlay, JL; et al. Pediatric Blood and Cancer. 2021.

Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database. Graham, RT; Coven, SL; Stanek, JR; Folta, A; Hollingsworth, EW; Finlay, JL; Kumar, R. Pediatric Blood and Cancer. 2021; 68.

Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients. Graham, RT; Bell, EH; Webb, A; Zhao, Y; Timmers, C; Fleming, JL; Sells, BE; Robison, NJ; Palmer, JD; Finlay, JL; et al. Journal of Pediatric Hematology/Oncology. 2020.

MBCL-06. SUCCESSFUL SALVAGE OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA PATIENTS TREATED ON ACNS1221. Graham, RT; Conley, S; Finlay, JL; AbdelBaki, MS. Neuro-Oncology. 2018; 20:i118-i118.

LGG-33. MEK-INHIBITOR MONOTHERAPY TO TREAT CONCURRENT OPTIC GLIOMA AND METASTATIC NEUROBLASTOMA IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1 (NF1). Belsky, J; Graham, R; Leonard, J; Finlay, J; Jones, J; Boué, D; Ranalli, M; AbdelBaki, M. Neuro-Oncology. 2018; 20:i111-i111.

HGG-30. PEDIATRIC GLIOSARCOMA WITH AND WITHOUT NEUROFIBROMATOSIS TYPE 1: A WHOLE-EXOME COMPARISON OF TWO PATIENTS. Graham, RT; Bell, EH; Webb, A; Timmers, C; Robison, N; Palmer, J; Finlay, JL; Chakravarti, A. Neuro-Oncology. 2018; 20:i95-i95.

Breaking Down Blood: Pediatric Immune Thrombocytopenia and Autoimmune Hemolytic Anemia in the Emergency Department. Graham, R; Rose, MJ. Clinical Pediatric Emergency Medicine. 2018; 19:122-130.

RARE-28. MALIGNANT TRANSFORMATION OF A LOW-GRADE MIDLINE GLIOMA WITH CONCOMITANT BRAFv600E AND H3.3K27 MUTATIONS. Graham, R; AbdelBaki, MS; Finlay, JL. Neuro-Oncology. 2017; 19:vi216-vi216.